|4Feb 20, 3:00 PM ET

TRANSGENOMIC INC 4

4 · TRANSGENOMIC INC · Filed Feb 20, 2014

Insider Transaction Report

Form 4
Period: 2014-02-18
COLONNESE MARK P
Chief Financial Officer
Transactions
  • Award

    Purchase Option

    2014-02-18+7,0007,000 total
    Exercise: $5.54From: 2016-02-18Exp: 2024-02-17Common Stock (7,000 underlying)
  • Award

    Purchase Option

    2014-02-18+7,0007,000 total
    Exercise: $5.54From: 2017-02-18Exp: 2024-02-17Common Stock (7,000 underlying)
  • Award

    Purchase Option

    2014-02-18+7,0007,000 total
    Exercise: $5.54From: 2015-02-18Exp: 2024-02-17Common Stock (7,000 underlying)
Footnotes (2)
  • [F1]Common Stock, par value $.01 per share of Transgenomic, Inc.
  • [F2]The various numbers listed in Columns 5, 7 and 9 relate to a single option grant which entitles the reporting person to purchase up to an aggregate of 21,000 shares of Common Stock, par value $.01 per share of Transgenomic, Inc.

Documents

1 file
  • 4
    v369304_4.xmlPrimary

    OWNERSHIP DOCUMENT